Table 1. Approximate dates of antiviral therapy used at the University of California Los Angeles.

Drug regimen	Years utilized
Pegylated-interferon and ribavirin	2005 to 2010
Pegylated-interferon, ribavirin, and boceprevir	2011 to 2013
All-oral direct-acting agents*	2014

^*sofosbuvir+ribavirin; sofosbuvir+simeprevir; sofosbuvir+ledipasvir; sofosbuvir+daclatasvir; sofosbuvir+elbasvir+grazoprevir+ribavirin.